Cantos Ventures is a San Francisco venture capital firm founded in 2016 that invests in what it calls 'near frontier' technology — advances that make previously intractable problems newly solvable. The firm backs technical founders and science-forward companies at pre-seed and seed stages, and it prefers to be a startup's first investor, taking technical risk alongside founders when other firms still see only risk.

Thesis

Cantos argues that the world's biggest problems — climate change, disease, poverty, conflict and existential risk — will be solved by building real things in the real world, not by another software layer. Its own site frames the mission as three paths: abundance, providing shelter, safety, food, water, energy and health more cheaply; resilience, strengthening critical systems and infrastructure; and advantage, keeping the United States and its democratic allies competitive in advanced technologies.

Sectors and stages

The firm invests at pre-seed and seed stages across climate, TechBio, aerospace and next-generation computing, with additional interest in industrial technology, machine intelligence in manufacturing and logistics, and decentralised finance within finance and healthcare. It is geographically centred on the United States but backs founders wherever the science leads.

Fund size and cheque size

Cantos closed its third fund, Cantos 3, at $50 million in September 2022, focused on pre-seed and seed investments in deeply technical climate, TechBio, aerospace and next-generation computing startups. The firm typically invests $500,000 to $1 million as a first cheque, and its earlier funds bring total assets under management to more than $50 million.

Portfolio

Named portfolio companies include Astranis, which is making satellite connectivity cheaper; Radiant, building portable fission reactors; Atom Computing, a quantum computing company; Solugen, which turns sugar into chemicals; Twelve, transforming captured carbon dioxide into chemicals; Skyryse, making air travel safer through avionics; Faeth Therapeutics, using nutrition to fight cancer; Venus Aerospace, a hypersonic company; and Mission Barns, producing cultivated fat for alternative meat. Its own site also highlights Andean Systems, where it led the pre-seed round, and Neros, building autonomous defence systems.

Partners and programmes

Ian Rountree, founder and general partner, founded Cantos in 2016 after early roles at SoFi and Invisible Technologies. Grant Gregory joined as partner in 2024 from a16z's American Dynamism team, where he led investments in Castelion and Salient Motion. Amee Kapadia, principal, joined in 2021 and leads investments across AI, biotech and robotics, while Sofia Garcia serves as chief financial officer.

How to apply for funding from Cantos Ventures

Cantos does not run a public application form. Its site's invitation is blunt — 'if you feel the weight of the future on your shoulders... come talk to us' — and general enquiries go to [email protected]. Founders should approach with a crisp account of the problem, why it is newly solvable, and why they are the team to solve it; Cantos says it backs people it considers 'legends in the making', so ambition and relentlessness are part of the pitch.

Why it matters for founders

For science-forward founders at the very earliest stage, Cantos offers a first investor that genuinely wants technical risk rather than tolerating it. Its near-frontier lens suits teams whose breakthrough is real but whose market looks unfamiliar — provided the founder can explain why now, and why them.